Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FYQ19
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,106
Award facts
- Contract value 100% obligated
- $25,106.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,106.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Exparel 266 mg/20 ml vials. This firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of October 8, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform the work at its facility in Park Ridge, Illinois, and deliver the pharmaceutical product to support the Defense Department's medical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. Exparel, a local anesthetic medication, represents one of many specialized pharmaceutical products the contractor supplies to federal healthcare systems as part of its established role as a critical supplier in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FYQ19?
SPE2DB25FYQ19 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FYQ19 worth?
The government has obligated $25,106 on SPE2DB25FYQ19.
Is contract SPE2DB25FYQ19 an order under another contract?
Yes. SPE2DB25FYQ19 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYQ19 competed?
The extent of competition for SPE2DB25FYQ19 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award